arrow
D

De Risi, Ivana

irccs istituto tumori bari giovanni paolo ii
H指数:0
被引数:26

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients

利用液体活检生物标志物开发风险评分,以筛选免疫治疗应答者并分层评估转移性黑色素瘤患者的疾病进展风险

2025-02-050
OA
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023-07-015
PRE
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma
2022-04-0523
OAAI
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
2021-11-0826
OAAI